{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:29:22Z","timestamp":1785774562315,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T00:00:00Z","timestamp":1492041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["R01HL36310"],"award-info":[{"award-number":["R01HL36310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"crossref","award":["RG\/13\/2\/30098"],"award-info":[{"award-number":["RG\/13\/2\/30098"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015223","name":"Danish Diabetes Academy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MR\/K013351\/1"],"award-info":[{"award-number":["MR\/K013351\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00125-017-4275-6","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T04:08:03Z","timestamp":1492056483000},"page":"1252-1260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study"],"prefix":"10.1007","volume":"60","author":[{"given":"Adam","family":"Hulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"F\u00e6rch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Vistisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoyo","family":"Ikehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam G.","family":"Tab\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,13]]},"reference":[{"key":"4275_CR1","doi-asserted-by":"publisher","first-page":"688","DOI":"10.2337\/diacare.26.3.688","volume":"26","author":"The DECODE Study Group","year":"2003","unstructured":"The DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688\u2013696","journal-title":"Diabetes Care"},{"key":"4275_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00125-010-1914-6","volume":"54","author":"P Chamnan","year":"2011","unstructured":"Chamnan P, Simmons RK, Jackson R, Khaw KT, Wareham NJ, Griffin SJ (2011) Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 54:291\u2013299","journal-title":"Diabetologia"},{"key":"4275_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00125-014-3448-9","volume":"58","author":"S Ikehara","year":"2015","unstructured":"Ikehara S, Tabak AG, Akbaraly TN et al (2015) Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study. Diabetologia 58:534\u2013542","journal-title":"Diabetologia"},{"key":"4275_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1464-5491.2010.03216.x","volume":"28","author":"N Holman","year":"2011","unstructured":"Holman N, Forouhi NG, Goyder E, Wild SH (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 28:575\u2013582","journal-title":"Diabet Med"},{"key":"4275_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/dmrr.1078","volume":"26","author":"F Ning","year":"2010","unstructured":"Ning F, Qiao Q, Tuomilehto J et al (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26:245\u2013253","journal-title":"Diabetes Metab Res Rev"},{"key":"4275_CR6","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1210\/jcem.86.11.7992","volume":"86","author":"A Raji","year":"2001","unstructured":"Raji A, Seely EW, Arky RA, Simonson DC (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366\u20135371","journal-title":"J Clin Endocrinol Metab"},{"key":"4275_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2337\/dc12-0544","volume":"36","author":"T Tillin","year":"2013","unstructured":"Tillin T, Hughes AD, Godsland IF et al (2013) Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent revisited (SABRE) cohort. Diabetes Care 36:383\u2013393","journal-title":"Diabetes Care"},{"key":"4275_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S2213-8587(15)00326-5","volume":"3","author":"N Sattar","year":"2015","unstructured":"Sattar N, Gill JM (2015) Type 2 diabetes in migrant South Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol 3:1004\u20131016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4275_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcte.2016.02.004","volume":"4","author":"UP Gujral","year":"2016","unstructured":"Gujral UP, Mohan V, Pradeepa R et al (2016) Ethnic variations in diabetes and prediabetes prevalence and the roles of insulin resistance and beta-cell function: the CARRS and NHANES studies. J Clin Transl Endocrinol 4:19\u201327","journal-title":"J Clin Transl Endocrinol"},{"key":"4275_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/jama.2009.726","volume":"301","author":"JC Chan","year":"2009","unstructured":"Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129\u20132140","journal-title":"JAMA"},{"key":"4275_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/dme.12016","volume":"30","author":"RS Bhopal","year":"2013","unstructured":"Bhopal RS (2013) A four-stage model explaining the higher risk of type 2 diabetes mellitus in South Asians compared with European populations. Diabet Med 30:35\u201342","journal-title":"Diabet Med"},{"key":"4275_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2337\/db09-9028","volume":"58","author":"RA DeFronzo","year":"2009","unstructured":"DeFronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773\u2013795","journal-title":"Diabetes"},{"key":"4275_CR13","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tabak","year":"2012","unstructured":"Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379:2279\u20132290","journal-title":"Lancet"},{"key":"4275_CR14","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","volume":"373","author":"AG Tabak","year":"2009","unstructured":"Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215\u20132221","journal-title":"Lancet"},{"key":"4275_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S2213-8587(13)70008-1","volume":"1","author":"K F\u00e6rch","year":"2013","unstructured":"F\u00e6rch K, Witte DR, Tabak AG et al (2013) Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 1:43\u201351","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4275_CR16","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","author":"World Health Organization","year":"2006","unstructured":"World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation. WHO, Geneva"},{"key":"4275_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.diabres.2011.03.012","volume":"93","author":"World Health Organization","year":"2011","unstructured":"World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299\u2013309","journal-title":"Diabetes Res Clin Pract"},{"key":"4275_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487\u20131495","journal-title":"Diabetes Care"},{"key":"4275_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0168-8227(99)00116-3","volume":"47","author":"M Gutt","year":"2000","unstructured":"Gutt M, Davis CL, Spitzer SB et al (2000) Validation of the insulin sensitivity index (ISI0,120): comparison with other measures. Diabetes Res Clin Pract 47:177\u2013184","journal-title":"Diabetes Res Clin Pract"},{"key":"4275_CR20","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/archinte.164.17.1873","volume":"164","author":"M Kumari","year":"2004","unstructured":"Kumari M, Head J, Marmot M (2004) Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Int Med 164:1873\u20131880","journal-title":"Arch Int Med"},{"key":"4275_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2337\/diabetes.53.1.160","volume":"53","author":"E Ferrannini","year":"2004","unstructured":"Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160\u2013165","journal-title":"Diabetes"},{"key":"4275_CR22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1464-5491.2007.02225.x","volume":"24","author":"E Laspa","year":"2007","unstructured":"Laspa E, Christen A, Efstathiadou Z, Johnston DG, Godsland IF (2007) Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis. Diabet Med 24:1269\u20131278","journal-title":"Diabet Med"},{"key":"4275_CR23","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2337\/db06-1256","volume":"56","author":"N Sattar","year":"2007","unstructured":"Sattar N, McConnachie A, Ford I et al (2007) Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984\u2013991","journal-title":"Diabetes"},{"key":"4275_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12020-007-0002-2","volume":"31","author":"J Hong","year":"2007","unstructured":"Hong J, Gu WQ, Zhang YF et al (2007) The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses. Endocrine 31:93\u201399","journal-title":"Endocrine"},{"key":"4275_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2337\/diabetes.55.04.06.db05-1109","volume":"55","author":"AH Xiang","year":"2006","unstructured":"Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074\u20131079","journal-title":"Diabetes"},{"key":"4275_CR26","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.2337\/db07-0053","volume":"56","author":"CC Mason","year":"2007","unstructured":"Mason CC, Hanson RL, Knowler WC (2007) Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 56:2054\u20132061","journal-title":"Diabetes"},{"key":"4275_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1177\/1479164112467545","volume":"10","author":"LM Goff","year":"2013","unstructured":"Goff LM, Griffin BA, Lovegrove JA et al (2013) Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome. Diab Vasc Dis Res 10:315\u2013323","journal-title":"Diab Vasc Dis Res"},{"key":"4275_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0140-6736(91)91164-P","volume":"337","author":"PM McKeigue","year":"1991","unstructured":"McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382\u2013386","journal-title":"Lancet"},{"key":"4275_CR29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1464-5491.2008.02597.x","volume":"25","author":"MA Abdul-Ghani","year":"2008","unstructured":"Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289\u20131294","journal-title":"Diabet Med"},{"key":"4275_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1097\/01.mco.0000171130.23441.59","volume":"8","author":"A Mari","year":"2005","unstructured":"Mari A, Ahren B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529\u2013533","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4275_CR31","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jama.2010.297","volume":"303","author":"S Stringhini","year":"2010","unstructured":"Stringhini S, Sabia S, Shipley M et al (2010) Association of socioeconomic position with health behaviors and mortality. JAMA 303:1159\u20131166","journal-title":"JAMA"},{"key":"4275_CR32","doi-asserted-by":"publisher","first-page":"e5452","DOI":"10.1136\/bmj.e5452","volume":"345","author":"S Stringhini","year":"2012","unstructured":"Stringhini S, Tabak AG, Akbaraly TN et al (2012) Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 345:e5452","journal-title":"BMJ"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-017-4275-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-017-4275-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T15:18:39Z","timestamp":1719155919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-017-4275-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,13]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4275"],"URL":"https:\/\/doi.org\/10.1007\/s00125-017-4275-6","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,13]]},"assertion":[{"value":"25 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Whitehall II data are available to bona fide researchers for research purposes. Please refer to the Whitehall II data sharing policy at.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"AH, RKS and DRW are supported by the Danish Diabetes Academy. The Danish Diabetes Academy is funded by the Novo Nordisk Foundation. RKS is further supported by the Aarhus Institute of Advanced Studies. KF is supported by the Novo Nordisk Foundation. EJB is supported by the British Heart Foundation (RG\/13\/2\/30098).The UK Medical Research Council (MR\/K013351\/1; G0902037), the British Heart Foundation (RG\/13\/2\/30098) and the US National Institutes of Health (R01HL36310, R01AG013196) have supported collection of data in the Whitehall II study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"AH was responsible for the data analysis. RKS and AH wrote the first draft of the manuscript with major contributions from AGT. EJB had the original idea for the study. AGT, MK and EJB contributed to the conception and design of the study and the data acquisition. All authors contributed to the interpretation of the data and critical revision of the manuscript, and approved the final version. AH is the guarantor of this work and, as such, had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}